Akoya Biosciences UK Ltd.

Active11611409 Private limited company

Incorporated: 8 October 2018 (8 years)
Industry: Research and experimental development on biotechnology (72110)
Directors: Jason Faessler
Everett Vaughan Cunningham
Owned by: Akoya Biosciences, Inc.
Accounts type: Small
Region: South East
Address: 2 Minton Place
Victoria Road
Bicester
OX26 6QB

Filing status

Accounts due: 31 December 2026
Last accounts: 31 December 2024
Conf. stmt due: 21 October 2027
Last conf. stmt: 7 October 2026

Charges

Total: 3
Outstanding: 2
Part satisfied: 0
Satisfied: 1

Officers 2 active

Officer details are public data from the Companies House register.

Faessler, Jason

Director · Appointed 22 June 2026

American

Born March 1976 (50)

Cunningham, Everett Vaughan

Director · Appointed 19 January 2026

American

Born January 1967 (59)

Officer history (6 former)

22 June 2026

Appointed Faessler, Jason as Director

15 June 2026

Resigned Sriram, Vandana as Director

19 January 2026

Appointed Cunningham, Everett Vaughan as Director

19 January 2026

Resigned Toloue, Masoud as Director

25 August 2025

Resigned Mckelligon, Brian as Director

25 August 2025

Appointed Toloue, Masoud as Director

25 August 2025

Appointed Sriram, Vandana as Director

25 August 2025

Resigned Ek, Johnny Frederick as Director

21 March 2023

Appointed Ek, Johnny Frederick as Director

21 March 2023

Resigned Driscoll, Joseph as Director

21 December 2021

Appointed Driscoll, Joseph as Director

27 February 2019

Resigned Ohs Secretaries Limited as Corporate Secretary

8 October 2018

Appointed Ohs Secretaries Limited as Corporate Secretary

8 October 2018

Appointed Mckelligon, Brian as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Akoya Biosciences, Inc.

Corporate entity · Notified 15 April 2021

Owns 75–100% of shares

Holds 75–100% of voting rights

Corporation

Reg. no. 5862695

Former controllers (3)

25 August 2025

Ceased John Frederick Ek — Has significant influence or control

25 August 2025

Ceased Brian Mckelligon — Has significant influence or control

21 March 2023

Ceased Joseph Driscoll — Has significant influence or control

Financials

Balance sheet as at 31 December 2024 · small accounts

Cash: £128,519
Profit: £5,333

Current Ratio: 2.1x
Return on Equity: 1%

Trend

Shareholder Funds

Balance sheet detail

	2024	2023	2022	2021	2020	2019
Fixed Assets	£11,411	£7,332	£6,673
Current Assets	£1,227,569	£1,109,266	£9,675,039	£4,332,087	£936,940	£400,803
Debtors	£1,099,050	£1,004,239	£9,450,850	£4,279,138	£875,973	£331,927
Cash	£128,519	£105,027	£224,189	£52,949	£60,967	£68,876
Creditors (< 1 year)	£583,608	£589,344	£9,235,107	£4,029,435	£800,922	£332,467
Net Current Assets	£643,961	£519,922	£439,932	£302,652	£136,018	£68,336
Shareholder Funds	£655,372	£527,254	£446,605	£302,652	£136,018	£68,336

Turnover				£3,179,822
Admin Expenses				£3,098,111
Staff Costs				£1,875,270
Operating Profit				£81,711
Profit Before Tax				£81,714
Tax				£9,502	£17,815
Profit for Period	£5,333	£4,114	£62,083	£72,212